HLS Therapeutics Inc.
HLTRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $17 | $22 | $21 | $21 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $8 | $11 | $11 | $12 |
| Inventory | $9 | $10 | $9 | $9 |
| Other Curr. Assets | $1 | $2 | $4 | $4 |
| Total Curr. Assets | $35 | $44 | $44 | $44 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $122 | $162 | $195 | $229 |
| Long-Term Investments | $0 | $0 | $1 | $1 |
| Tax Assets | $1 | $1 | $0 | $1 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $125 | $165 | $197 | $232 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $160 | $209 | $242 | $276 |
| Liabilities | – | – | – | – |
| Payables | $9 | $14 | $12 | $9 |
| Short-Term Debt | $5 | $5 | $14 | $13 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $4 | $5 |
| Other Curr. Liab. | $8 | $7 | -$2 | -$4 |
| Total Curr. Liab. | $23 | $27 | $31 | $28 |
| LT Debt | $61 | $82 | $84 | $85 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $4 | $0 | $1 | $1 |
| Other NC Liab. | $1 | $2 | $1 | $3 |
| Total NC Liab. | $66 | $85 | $85 | $87 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $89 | $111 | $116 | $115 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $261 | $262 | $265 | $266 |
| Retained Earnings | -$194 | -$175 | -$148 | -$120 |
| AOCI | -$10 | -$3 | -$5 | $3 |
| Other Equity | $15 | $14 | $14 | $12 |
| Total Equity | $71 | $98 | $125 | $161 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $160 | $209 | $242 | $276 |
| Net Debt | $49 | $66 | $77 | $76 |